Your signal. Your price.
Peter Attia states breast cancer is the fourth-leading cause of cancer death after lung, colorectal, and pancreatic cancer.
Attia cites CISNET models showing annual mammography for women 40-79 yields a 42% mortality reduction versus 30% for biennial screening, translating to 230 life-years gained per 1,000 women annually versus 165 biennially.
Attia notes observational data shows women screening annually had an 11% interval cancer rate versus 38% for biennial screeners, and annual screening led to 76% stage one diagnoses versus 56% for biennial.
Attia argues aggressive cancers comprise 7-10% of cases, eluding even perfect screening, while underscreening is the larger, solvable problem.
Attia states about 20% of women 50-74 are not up-to-date on mammograms, and at least 9% qualify for MRI under guidelines but only 0.4% get it.
Attia recommends a formal risk assessment by age 25 to determine if you are truly average risk or need earlier, more intensive screening.
Attia says BRCA mutations occur in about 1 in 400 people overall but are more prevalent in Ashkenazi Jewish ancestry, while triple-negative cancers account for 20% of cases in women under 40 versus 6-12% in older women.
Attia notes breast cancer risk is cumulative; only about 5% of diagnoses occur under age 40, and cumulative risk through age 40 is less than 1%.
Attia cites a study of 6 million mammograms showing cancer detection rates: 2.1 per 1,000 for women 35-39 with risk factors versus 0.59 per 1,000 for average-risk women, and 0.71 per 1,000 for average-risk women 40-44.
Attia says triple-negative cancers can double in size in under four months, making annual screening insufficient for some high-risk younger women.
Attia states about 50% of screening-age women have dense breast tissue, which both raises baseline risk and reduces mammogram sensitivity.
Attia explains DCIS, found via mammography, has a 25-60% chance of progressing to invasive cancer, justifying its detection.
Attia notes adding MRI to mammography for dense breasts halved interval cancer rates from 5 per 1,000 to 2.5 per 1,000.
Attia cites studies showing handheld ultrasound added to 2D mammography increased detection by 4.2 per 1,000, while adding it to DBT only boosted detection by 1.1 per 1,000.
Attia argues inflammatory breast cancer accounts for 1-5% of cases, often lacks a discrete lump, and requires diagnostic workup as it may not appear on screening mammograms.
Curry critiques Tulsi Gabbard's statement on U.S.-funded biolabs for its robotic delivery, noting she revealed evidence of over 120 labs in 30 countries and Trump's 2025 executive order ending federal gain-of-function funding.
Jon describes his chicken system vulnerabilities: no rooster, reliance on automatic doors with faulty battery backups, and vulnerability to raccoon attacks.
Florida leads the US in lightning fatalities and strikes per square mile, with Rogan citing stats of 12 deaths and 76 strikes per mile.
Rogan cites the book 'Dissolving Illusions' to argue that DDT poisoning mimicked polio symptoms and was sprayed indiscriminately during the polio epidemic.
Bob Watcher says healthcare delivery remains sloppy due to high fixed costs, powerful incumbents, and a 'funky' economic model where customers don't directly choose vendors.
Watcher argues healthcare is the largest user of fax machines in the country and only recently ditched pagers after drug dealers did.
The transition from paper to digital records didn't transform medicine and in some ways made things worse, creating a 'productivity paradox' where technology failed to improve efficiency.
A 2012 JAMA crayon drawing by a seven-year-old captured the doctor-patient relationship breakdown, showing the doctor typing with his back turned.
Watcher says billing creates perverse incentives, as reimbursement hinges on how a doctor phrases notes, not just the care provided.
AI scribes using ambient intelligence now summarize patient conversations, grouping related symptoms and filtering out personal anecdotes, which restores eye contact and reduces physician 'pajama time'.
Watcher cites a case where a human error - misinterpreting 'PE' for physical exam as pulmonary embolism - stuck in a patient's record for 20 years, arguing AI summarization can reduce such mistakes despite hallucination risks.
Pierre Elias says traditional cardiovascular disease detection via cardiac catheterization is too invasive for healthy patients, and echocardiograms are too expensive for population screening, creating a diagnostic gap.
Elias's AI model, EchoNet, analyzed ECGs from nearly 20,000 patients and predicted structural heart disease with 78% accuracy, outperforming cardiologists at 64%.
In the CACTUS trial, AI screening in eight New York emergency departments found half of high-risk patients for undiagnosed structural heart disease weren't getting follow-up echocardiograms.
Watcher says Epic dominates the EHR market with records for 325 million people, winning through integrated solutions, but its closed system may slow AI innovation by locking out third-party tools.